Literature DB >> 16374844

Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence.

Snorri S Thorgeirsson1, Joe W Grisham.   

Abstract

The authors reviewed 77 published reports available before August 1, 2005 that examined the ability of hematopoietic cells to generate hepatocytes in the liver. A list of these publications and a synopsis of each are available on-line. We interpret the evidence provided by this data set to suggest that one or more types of hematopoietic cells may rarely acquire the hepatocyte phenotype in the liver (frequency < or =10(-4)), although the nature of the hematopoietic cells involved and the mechanisms responsible for acquisition of a hepatocyte phenotype are still controversial. Hematopoietic stem cells do not appear to be direct precursors of hepatocytes, which, instead, can be generated from cells of the macrophage-monocyte lineage. Fusion between hepatocytes and transplanted hematopoietic cells has been substantiated as a mechanism by which hepatocytes that carry a bone marrow tag are generated, but direct transdifferentiation of hematopoietic cells has not been demonstrated. In conclusion, hematopoietic cells contribute little to hepatocyte formation under either physiological or pathological conditions, although they may provide cytokines and growth factors that promote hepatocyte functions by paracrine mechanisms. Cells of the endodermal hepatocyte lineage are far more potent generators of hepatocytes than are hematopoietic cells.

Mesh:

Year:  2006        PMID: 16374844     DOI: 10.1002/hep.21015

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  56 in total

Review 1.  Artificial cell microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy.

Authors:  Zun Chang Liu; Thomas Ming Swi Chang
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  Stem cells in hepatocarcinogenesis: evidence from genomic data.

Authors:  Jens U Marquardt; Snorri S Thorgeirsson
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 3.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

Review 4.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

5.  Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells.

Authors:  P A Lysy; D Campard; F Smets; J Malaise; M Mourad; M Najimi; E M Sokal
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

6.  Passage of bone-marrow-derived liver stem cells in a proliferating culture system.

Authors:  Yun-Feng Cai; Ji-Sheng Chen; Shu-Ying Su; Zuo-Jun Zhen; Huan-Wei Chen
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

7.  Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes.

Authors:  Viktória László; Katalin Dezso; Kornélia Baghy; Veronika Papp; Ilona Kovalszky; Géza Sáfrány; Snorri S Thorgeirsson; Peter Nagy; Sándor Paku
Journal:  Histochem Cell Biol       Date:  2008-07-29       Impact factor: 4.304

8.  The identification of stem cells in human liver diseases and hepatocellular carcinoma.

Authors:  Joan Oliva; Barbara A French; X Qing; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-01-18       Impact factor: 3.362

Review 9.  Model systems and experimental conditions that lead to effective repopulation of the liver by transplanted cells.

Authors:  David A Shafritz; Michael Oertel
Journal:  Int J Biochem Cell Biol       Date:  2010-01-18       Impact factor: 5.085

Review 10.  Stem cells in liver regeneration and their potential clinical applications.

Authors:  Ioannis Drosos; George Kolios
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.